List of templates

Set of active templates structures:

# PDB CODE
(CHAIN)
UNIPROT
CODE
ORGANISM RECEPTOR
SUBFAMILY-TYPE
RESOLUTION
[]
# AMINO ACIDS
(PDB/UNIPROT)
FUSION PROTEIN FIRST AUTHOR JOURNAL YEAR LIGAND
CODE
LIGAND
ROLE
1 2Y02 (B) P07700 turkey adrenergic-beta1 2.60 298/483 none A. Warne NATURE 2011 WHJWHJ (B) ortho. agonist
2 2YDV (A) P29274 human adenosine-A2A 2.60 307/412 none G. Lebon NATURE 2011 NECNEC (A) ortho. agonist
3 3PQR (A) P02699 bovine rhodopsin 2.85 326/348 none H.W. Choe NATURE 2011 RETRET (A) ortho. agonist
4 3QAK (A) P29274 human adenosine-A2A 2.71 284/412 lysozyme F. Xu SCIENCE 2011 UKAUKA (A) ortho. agonist
5 3SN6 (R) P04896 bovine adrenergic-beta2 3.20 284/394 lysozyme S.G. Rasmussen NATURE 2011 P0GP0G (R) ortho. agonist
6 4GRV (A) P20789 rat neurotensin-R1 2.80 293/424 lysozyme J.F. White NATURE 2012 PEPTIDEPEPTIDE (A) ortho. agonist
7 4IAQ (A) P28222 human serotonin-1B 2.80 273/390 cytochrome C. Wang SCIENCE 2013 2GM2GM (A) ortho. agonist
8 4IAR (A) P28222 human serotonin-1B 2.70 273/390 cytochrome C. Wang SCIENCE 2013 ERMERM (A) ortho. agonist
9 4IB4 (A) P41595 human serotonin-2B 2.70 285/481 cytochrome D. Wacker SCIENCE 2013 ERMERM (A) ortho. agonist
10 4NC3 (A) P41595 human serotonin-2B 2.80 287/481 cytochrome W. Liu SCIENCE 2013 ERMERM (A) ortho. agonist
11 4PHU (A) O14842 human fatty-acid-R1 2.33 272/300 lysozyme A. Srivastava NATURE 2014 2YB2YB (A) allo. agonist
12 4PXZ (A) Q9H244 human purinergic-P2Y12 2.50 286/342 cytochrome J. Zhang NATURE 2014 6AD6AD (A) ortho. agonist
13 4PY0 (A) Q9H244 human purinergic-P2Y12 3.10 283/342 cytochrome J. Zhang NATURE 2014 6AT6AT (A) ortho. agonist
14 4QIN (A) Q99835 human smoothened 2.60 341/787 cytochrome C. Wang NAT. COMMUN. 2014 SG8SG8 (A) ortho. agonist
15 4UHR (A) P29274 human adenosine-A2A 2.60 308/412 none G. Lebon MOL. PHARMACOL. 2015 NGINGI (A) ortho. agonist
16 4XT1 (A) P69332 human chemokine-CX3CL1 2.89 291/354 none J.S. Burg SCIENCE 2015 proteinprotein (A) ortho. agonist
17 4XT3 (A) P69332 human chemokine-CX3CL1 3.80 288/354 none J.S. Burg SCIENCE 2015 proteinprotein (A) ortho. agonist
18 5C1M (A) P42866 mouse opioid-mu 2.10 295/398 none W. Huang NATURE 2015 4VO4VO (A) ortho. agonist
19 5G53 (A) P29274 human adenosine-A2A 3.40 279/412 none B. Carpenter NATURE 2016 NECNEC (A) ortho. agonist
20 5GLH (A) P24530 human endothelin-B 2.80 292/442 none W. Shihoya NATURE 2016 peptidepeptide (A) ortho. agonist
21 5NX2 (A) P43220 human 5NX2_A:* 3.70 389/463 none A. Jazayeri NATURE 2017 none none
22 5TVN (A) P41595 human serotonin-2B 2.90 293/481 cytochrome D. Wacker CELL 2017 7LD7LD (A) ortho. agonist
23 5UNG (A) P50052 human angiotensin-AT2R 2.80 300/363 cytochrome H. Zhang NATURE 2017 8ES8ES (A) ortho. ligand
24 5UZ7 (A) P63092 human calcitonin 4.10 266/394 none Y.L. Liang NATURE 2017 none none
25 5VAI (R) G1SGD4 rabbit glucagon-like-R1 4.10 387/462 none Y. Zhang NATURE 2017 none none
26 5VBL (A) P35414 human apelin-R 2.60 299/380 ruberodoxin Y. Ma STRUCTURE 2017 none none
27 5XR8 (A) P21554 human cannabinoid-CB1 2.95 285/472 flavodoxin T. Hua NATURE 2017 8D08D0 (A) ortho. agonist
28 5XRA (A) P21554 human cannabinoid-CB1 2.80 282/472 flavodoxin T. Hua NATURE 2017 8D38D3 (A) ortho. agonist
29 5YQZ (R) P47871 human glucagon 3.00 398/477 lysozyme H. Zhang NATURE 2018 none none
30 6B73 (A) P41145 human opioid-kappa 3.10 278/380 cytochrome T. Che CELL 2018 CVVCVV (A) ortho. agonist
31 6BQG (A) P28335 human serotonin-2C 3.00 286/458 cytochrome Y. Peng CELL 2018 ERMERM (A) ortho. agonist

Set of inactive templates structures:

# PDB CODE
(CHAIN)
UNIPROT
CODE
ORGANISM RECEPTOR
SUBFAMILY-TYPE
RESOLUTION
[]
# AMINO ACIDS
(PDB/UNIPROT)
FUSION PROTEIN FIRST AUTHOR JOURNAL YEAR LIGAND
CODE
LIGAND
ROLE
1 1GZM (A) P02699 bovine rhodopsin 2.65 329/348 none J. Li J. MOL. BIOL. 2004 RETRET (A) ortho. antagonist
2 1U19 (A) P02699 cattle rhodopsin 2.20 348/348 none T. Okada J. MOL. BIOL. 2004 RETRET (A) ortho. antagonist
3 2RH1 (A) P07550 human adrenergic-beta2 2.40 282/413 lysozyme V. Cherezov SCIENCE 2007 CAUCAU (A) ortho. antagonist
4 2VT4 (A) P07700 turkey adrenergic-beta1 2.7 276/483 lysozyme A. Warne NATURE 2008 P32P32 (A) ortho. antagonist
5 3EML (A) P29274 human adenosine-A2A 2.60 288/412 lysozyme V.P. Jaakola SCIENCE 2008 ZMAZMA (A) ortho. antagonist
6 3PBL (A) P35462 human dopamine-D3 2.89 272/400 lysozyme E.Y. Chien SCIENCE 2010 ETQETQ (A) ortho. antagonist
7 3RZE (A) P35367 human histamine-H1 3.10 268/487 lysozyme T. Shimamura NATURE 2011 5EH/D7V5EH/D7V (A) ortho. antagonist
8 3UON (A) P08172 human muscarinic-M2 3.00 278/466 lysozyme K. Haga NATURE 2012 QNBQNB (A) ortho. antagonist
9 3V2Y (A) P21453 human sphingosine-R1 2.80 291/382 lysozyme M.A. Hanson SCIENCE 2012 ML5ML5 (A) ortho. antagonist
10 3VW7 (A) P25116 human protease-activated-R1 2.20 282/425 lysozyme C. Zhang NATURE 2012 VPXVPX (A) ortho. antagonist
11 4DAJ (A) P08483 rat muscarinic-M3 3.40 268/589 lysozyme A.C. Kruse NATURE 2012 0HK0HK (A) ortho. antagonist
12 4DJH (A) P41145 human opioid-kappa 2.90 287/380 lysozyme H. Wu NATURE 2012 JDCJDC (A) ortho. antagonist
13 4DKL (A) P42866 mouse opioid-mu 2.80 282/398 lysozyme A. Manglik NATURE 2012 BF0BF0 (A) ortho. antagonist
14 4EA3 (A) P41146 human opioid-nociceptin 3.01 278/370 cytochrome A.A. Thompson NATURE 2012 0NN0NN (A) ortho. antagonist
15 4EIY (A) P29274 human adenosine-A2A 1.80 296/412 cytochrome W. Liu SCIENCE 2012 ZMAZMA (A) ortho. antagonist
16 4EJ4 (A) P32300 mouse opioid-delta 3.40 282/372 lysozyme S. Granier NATURE 2012 EJ4EJ4 (A) ortho. antagonist
17 4JKV (A) Q99835 human smoothened 2.45 346/787 cytochrome C. Wang NATURE 2013 1KS1KS (A) ortho. antagonist
18 4K5Y (A) P34998 human corticotropin-R1 2.98 247/444 lysozyme K. Hollenstein NATURE 2013 1Q51Q5 (A) ortho. antagonist
19 4L6R (A) P47871 human glucagon 3.30 292/477 cytochrome F.Y. Siu NATURE 2013 none none
20 4MBS (A) P51681 human chemokine-CCR5 2.71 292/352 ruberodoxin Q. Tan SCIENCE 2013 MRVMRV (A) ortho. antagonist
21 4N4W (A) Q0SXH8 human smoothened 2.80 348/787 cytochrome C. Wang NAT. COMMUN. 2014 SNTSNT (A) ortho. antagonist
22 4N6H (A) P41143 human opioid-delta 1.80 303/372 cytochrome G. Fenalti NATURE 2014 EJ4EJ4 (A) ortho. antagonist
23 4NTJ (A) Q9H244 human purinergic-P2Y12 2.62 267/342 cytochrome K. Zhang NATURE 2014 AZJAZJ (A) ortho. antagonist
24 4O9R (A) Q99835 human smoothened 3.20 335/787 cytochrome U. Weierstall NAT. COMMUN. 2014 CY8CY8 (A) ortho. antagonist
25 4OO9 (A) P41594 human glutamate-R5 2.60 245/1212 lysozyme A.S. Dore NATURE 2014 2U82U8 (A) negative allo. modulator
26 4OR2 (A) Q13255 human glutamate-R1 2.80 255/1194 cytochrome H. Wu SCIENCE 2014 FM9FM9 (A) negative allo. modulator
27 4QIM (A) Q99835 human smoothened 2.61 351/787 cytochrome C. Wang NAT. COMMUN. 2014 A8TA8T (A) ortho. antagonist
28 4RWA (A) P41143 human opioid-delta 3.28 286/372 cytochrome G. Fenalti NAT. STRUCT. MOL. BIOL. 2015 peptide ortho. antagonist
29 4RWD (A) P41143 human opioid-delta 2.70 295/372 cytochrome G. Fenalti NAT. STRUCT. MOL. BIOL. 2015 peptidepeptide (A) ortho. antagonist
30 4RWS (A) P61073 human chemokine-CXCR4 3.10 275/352 lysozyme L. Qin SCIENCE 2015 proteinprotein (A) ortho. antagonist
31 4XNV (A) P47900 human purinergic-P2Y1 2.20 290/373 ruberodoxin D. Zhang NATURE 2015 BURBUR (A) allo. antagonist
32 4XNW (A) P47900 human purinergic-P2Y1 2.70 292/373 ruberodoxin D. Zhang NATURE 2015 2ID2ID (A) ortho-allo. antagonist
33 4YAY (A) P30556 human angiotensin-AT1R 2.90 288/359 cytochrome H. Zhang CELL 2015 ZD7ZD7 (A) ortho. antagonist
34 4Z34 (A) Q92633 human lysophosphatidic-acid-R1 3.00 292/364 cytochrome J.E. Chrencik CELL 2015 ON7ON7 (A) ortho. antagonist
35 4Z35 (A) Q92633 human lysophosphatidic-acid-R1 2.90 289/364 cytochrome J.E. Chrencik CELL 2015 ON9ON9 (A) ortho. antagonist
36 4Z36 (A) Q92633 human lysophosphatidic-acid-R1 2.90 289/364 cytochrome J.E. Chrencik CELL 2015 ON3ON3 (A) ortho. antagonist
37 4Z9G (A) P34998 human corticotropin-R1 3.18 260/444 lysozyme A.S. Dore CURR. MOL. PHARMACOL. 2017 1Q51Q5 (A) ortho. antagonist
38 4ZUD (A) P30556 human angiotensin-AT1R 2.80 271/359 cytochrome H. Zhang J. BIOL. CHEM. 2015 OLMOLM (A) ortho. inverse agonist
39 5CGC (A) P41594 human glutamate-R5 3.10 248/1212 lysozyme J.A. Christopher J. MED. CHEM. 2015 51D51D (A) negative allo. modulator
40 5CGD (A) P41594 human glutamate-R5 2.60 247/1212 lysozyme J.A. Christopher J. MED. CHEM. 2015 51E51E (A) negative allo. modulator
41 5D6L (A) P07550 human adrenergic-beta2 3.20 280/413 lysozyme P. Ma NAT. PROTOC. 2017 CAUCAU (A) ortho. antagonist
42 5DHG (A) P41146 human opioid-nociceptin 3.00 281/370 cytochrome R.L. Miller STRUCTURE 2015 DGVDGV (A) ortho. antagonist
43 5DHH (A) P41146 human opioid-nociceptin 3.00 282/370 cytochrome R.L. Miller STRUCTURE 2015 DGWDGW (A) ortho. antagonist
44 5EE7 (A) P47871 human glucagon 2.50 257/477 lysozyme A. Jazayeri NATURE 2016 5MV5MV (A) allo. antagonist
45 5F8U (A) P07700 turkey adrenergic-beta1 3.35 276/483 none A.G.W. Leslie NAT. STRUCT. MOL. BIOL. 2015 P32P32 (A) ortho. antagonist
46 5GLI (A) P24530 human endothelin-B 2.50 312/442 none W. Shihoya NATURE 2016 none none
47 5IU4 (A) P29274 human adenosine-A2A 1.72 294/412 cytochrome E. Segala J. MED. CHEM. 2016 ZMAZMA (A) ortho. antagonist
48 5JQH (A) P00720 human adrenergic-beta2 3.20 283/413 lysozyme D.P. Staus NATURE 2016 CAUCAU (A) ortho. antagonist
49 5L7D (A) Q99835 human smoothened 3.20 483/787 cytochrome E.F. Byrne NATURE 2016 CLRCLR (A) CRD bound ligand
50 5L7I (A) Q99835 human smoothened 3.30 467/787 cytochrome E.F. Byrne NATURE 2016 VISVIS (A) ortho. antagonist
51 5LWE (A) P51686 human chemokine-CCR9 2.80 271/369 none C. Oswald NATURE 2016 79K79K (A) ortho. antagonist
52 5NDD (A) D9IEF7 human protease-activated-R2 2.80 295/397 cytochrome R.K.Y. Cheng NATURE 2017 8TZ8TZ (A) ortho. antagonist
53 5T1A (A) P41597 human chemokine-CCR2 2.81 283/374 lysozyme Y. Zheng NATURE 2016 VT5VT5 (A) allo. antagonist
54 5T1A (A) P41597 human chemokine-CCR2 2.81 283/374 lysozyme Y. Zheng NATURE 2016 73R73R (A) ortho. antagonist
55 5TGZ (A) P21554 human cannabinoid-CB1 2.80 289/472 flavodoxin T. Hua CELL 2016 ZDGZDG (A) ortho. antagonist
56 5U09 (A) P21554 human cannabinoid-CB1 2.60 282/472 none Z. Shao NATURE 2016 7DY7DY (A) ortho. antagonist
57 5UEN (A) P30542 human adenosine-A1A 3.20 292/326 cytochrome A. Glukhova CELL 2017 none none
58 5UIG (A) P29274 human adenosine-A2A 3.50 288/412 cytochrome B. Sun PROC. NATL. ACAD. SCI. 2017 8D18D1 (A) ortho. antagonist
59 5VEW (A) P43220 human glucagon-like-R1 2.70 262/463 lysozyme G. Song NATURE 2017 97Y97Y (A) negative allo. modulator
60 5VEX (A) P43220 human glucagon-like-R1 3.00 262/463 lysozyme G. Song NATURE 2017 97V97V (A) negative allo. modulator
61 5XEZ (A) P47871 human glucagon 3.00 389/477 lysozyme H. Zhang NATURE 2017 97V97V (A) negative allo. modulator
62 5XF1 (A) P47871 human glucagon 3.19 389/477 lysozyme H. Zhang NATURE 2017 97V97V (A) negative allo. modulator
63 6BQH (A) P28335 human serotonin-2C 2.70 287/458 cytochrome Y. Peng CELL 2018 E2JE2J (A) ortho. antagonist

Abbreviations

ortho.-orthosteric
allo.-allosteric
neg.-negative

Ligand images

The images of ligand interactions were created using the PoseView service of the Center for Bioinformatics Hamburg. The details how the interactions are determined are described in [K. Stierand, M. Rarey (2010), Drawing the PDB: Protein-ligand complexes in two dimensions, ACS Med. Chem. Lett., DOI: 10.1021/ml100164p].

This service uses cookies.